MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611060747 A) filed by Geeta University on May 13, 2026, for Nanoparticle-Based Mrna Carrier System For Intranasal Delivery And A Method Of Preparation Thereof.
Inventors include Naveen Deshwal; Dr. Seema Rohilla; and Ms. Twinkle.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The present invention discloses a nanoparticle-based mRNA carrier system for intranasal delivery and a method of preparation thereof. The system comprises biocompatible nanoparticles encapsulating messenger RNA and optionally modified with PEGylation and mucoadhesive agents to enhance stability, reduce immunogenicity, and improve nasal retention. The nanoparticles protect mRNA from enzymatic degradation and enable controlled release and efficient uptake through nasal mucosa. The method includes formation of nanoparticles, encapsulation of mRNA, surface modification, and formulation into an intranasal dosage form. The invention represents a novel means for delivering mRNA for the purposes of vaccines, gene therapies, and treatment without any risk of infection, providing increased bioavailability, lowered immunity response, and higher patient compliance than previous delivery systems.
Disclaimer: Curated by HT Syndication.
